What is IBScheck test?
IBSchek is a simple ELISA*-based blood test that is highly predictive of an IBS diagnosis based on the presence of two antibodies—anti-CdtB and anti-vinculin. In a study of more than 2,500 patients conducted in 180 centers around the U.S., IBSchek was found to be more commonly positive in IBS with diarrhea (IBS-D) or IBS with mixed symptoms (IBS-M) compared to patients with Crohn’s disease, ulcerative colitis, and celiac disease. IBSchek is the first clinically validated blood test to confirm a diagnosis of either IBS-D or IBS-M. *ELISA = enzyme-linked immunosorbent assay.
What does the test measure?
IBSchek was developed based on the scientific discovery that irritable bowel syndrome often results from a previous episode of gastroenteritis. IBSchek tests for the presence of antibodies in the blood that were created by alterations in the intestinal microbiota resulting from acute gastroenteritis. It detects levels of an antibody to a toxin called CdtB (cytolethal distending toxin B), as well as vinculin, a human protein commonly found in nerves and the lining of the gut. While the test is more specific for anti-CdtB, the anti-vinculin component suggests that irritable bowel syndrome may be an autoimmune disease. The two levels enable a differential diagnosis of IBS from inflammatory bowel disease (IBD).
How do you test for IBS?
-
IBS has traditionally been diagnosed using multiple tests to exclude the possibility of other diseases. If no other health issues are found, a diagnosis of IBS is made.
-
Scientists have since discovered validated biomarkers for IBS that can be measured with a blood test. These biomarkers are effective in diagnosing the majority of IBS-D and IBS-M cases.
-
IBSchek Test is the only licensed, patented blood test that measures these biomarkers to diagnose IBS.
If your IBScheck test results are positive:
- You know with certainty that you have IBS. The organic biomarkers tested by ibs-check test have a positive predictive value of IBS that is 96%-100%.
- You know the cause, which can help personalize treatment.
- If the measured biomarkers are elevated, your IBS developed from gastroenteritis (food poisoning). This means your gut microbiome has been disrupted, indicating that treatments that target the gut microbiome could be effective for you.
Getting the IBScheck test could help avoid years of additional testing and costs.
IBSchek® – The First Clinically Validated Blood Test for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D) and Mixed Symptoms (IBS-M).
Now only $420 with available at-home Capillary Collection Kit!*
IBS and SIBO-Is there a connection?
It is now known, based on extensive human and animal research, that acute gastroenteritis leads to IBS. In animal studies, infection with campylobacter jejuni (C. jejuni) caused small intestinal bacterial overgrowth. C. jejuni infection also leads to the production of the anti-CdtB and anti-vinculin antibodies detected by IBSchek.
In the same animal studies, antibody levels were related to the number of infections the animals experienced. However, irrespective of the number of infections with C. jejuni, bacterial overgrowth was more closely related to the antibodies than the number of infections.
Here’s how food poisoning leads to IBS. (Watch Dr Hagmeyer’s Video below)
IBSchek has been validated in diagnosing irritable bowel syndrome associated with diarrhea and mixed symptoms. Published studies have determined the cost savings—both direct and indirect—to the patient and healthcare system from receiving a faster diagnosis.
Does IBScheck suggest what treatment is best for me?
A positive IBSchek can confirm that you have IBS-S or IBS-M and that your disease is an organic condition based on the presence of validated biomarkers. IBSchek does not offer insight into which treatment is best for your irritable bowel syndrome patient. If this test is positive, Dr Hagmeyer may recommend additional testing.
IBSchek Capillary Collection Kit
The IBSchek Capillary Collection Kit offers direct patient access, simple and safe sample collection, free shipping included, and easy-to-understand results in just a few days.**
The IBSchek Capillary Kit is one of the tests we use to help our patients quickly and reliably diagnose diarrhea-predominant or mixed-symptom IBS (IBS-D/M). Symptoms of this chronic ailment often occur following an incident of acute gastroenteritis (food poisoning).
IBSchek is performed in a CLIA-certified laboratory and results can provide you and your health care provider with actionable clinical data and a better understanding of your health.
The IBSchek Capillary Kit and consult with Dr Hagmeyer Includes:
- Test Requisition Form;
- Easy-to-follow Instructions for Use;
- Sterile Collection and Return Materials; and
- Pre-Paid Return Shipping Label
- 30 minute Consult with Dr Hagmeyer
Consult with Dr Hagmeyer
- Every test ordered through the DrHagmeyer.com website includes the following
- The ordering of the test kit on your behalf
- Interpretation of testing
- 30 minute consult with to discuss lab testing findings and recommendation on what to do next.
- Return shipping to lab
About CDI
Commonwealth Diagnostics International, Inc. is a CLIA-certified independent laboratory operating out of a state-of-the-art laboratory located in Salem, Massachusetts. In lieu of expensive, invasive, and inaccessible diagnostic methods, CDI provides non-invasive and cost-effective tools to empower patients by providing meaningful information about their gastrointestinal condition.
About IBSchek Test
IBSchek is a proprietary blood test for IBS based on the scientific findings of a 2500+ patient clinical trial which showed that anti-vinculin and anti-CdtB are effective biomarkers for the diagnosis of diarrhea-predominant or mixed-symptom IBS. Irritable Bowel Syndrome (IBS) is the most common functional gastrointestinal syndrome in the U.S. It is estimated that up to 45 million people, or 10-15% of the American population, suffer from IBS.
FAQ
Q. What is IBSchek?
IBSchek is a proprietary blood test for IBS based on the scientific findings of a 2500+ patient clinical trial which showed that anti-vinculin and anti-CdtB are effective biomarkers for the diagnosis of diarrhea-predominant or mixed-symptom IBS. Click here to read published clinical data validating IBSchek for diagnosing IBS-D and IBS-M.
Q. What is an IBSchek capillary collection kit?
IBSchek can be performed using our at-home capillary collection kit. The kit includes the test requisition form, easy-to-follow instructions for use, sterile collection and return materials, and pre-paid return shipping materials.
Q. How quickly can I receive results from your lab?
When the sample arrives at our laboratory, it will be analyzed within 24-48 hours. When our office has been notified of your test Results and Dr Hagmeyer has reviewed them, you will be contacted to schedule a 30 minute consult with Dr Hagmeyer or one of his associates.
Published Clinical Data Validating IBSchek for Diagnosing IBS-D and IBS-M
**Result data should be interpreted with the help of a qualified health care provider and all clinical decisions should consider other symptoms and health factors in disease diagnosis and management.
